Physician

Charles Harry Kemp, M.D.

According to 2025 Medicare claims, Charles Kemp, M.D. (NPI: 1093035784) practices internal medicine in the Albany, GA market, with the plurality of this provider's patient population coming from Dougherty, GA. This provider's primary affiliated billing organization is PRIVIA MEDICAL GROUP OF GEORGIA LLC (NPI: 1013313857; TIN: 202265068) and primary practice location at 31707-0205. Kemp is affiliated with the Privia Quality Network of Georgia (ACO ID: A3236) and Caravan Health ACO 50 LLC (ACO ID: A5160), participating under the MSSP model.

Kemp's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 694 traditional Medicare patients, billed 15,244 HCPCS/CPT codes, and received $351,848 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 21,716 prescription claims across 1,173 beneficiaries totaling $2,113,734 in drug costs, led by Ozempic (Semaglutide). DME data shows 806 claims. Open Payments data shows 169 records totaling $741,371. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have risen steadily, from $776,886 to $2,113,734. In contrast, DME billing represents a smaller volume and moved from a lower plateau to a higher plateau, from $21,717 to $59,900.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	768	12,206	$343,053
2016	739	11,717	$303,122
2017	945	12,813	$362,368
2018	770	12,704	$318,218
2019	833	12,582	$334,299
2020	779	11,832	$330,466
2021	738	11,818	$349,806
2022	683	11,618	$332,045
2023	734	13,044	$382,796
2024	694	15,244	$351,848

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	763	16,712	$776,886
2016	790	17,074	$866,422
2017	925	17,708	$1,031,724
2018	961	17,386	$1,226,393
2019	1,005	17,151	$1,263,765
2020	986	16,883	$1,293,780
2021	1,000	17,587	$1,436,188
2022	1,096	18,970	$1,735,341
2023	1,101	19,895	$2,063,316
2024	1,173	21,716	$2,113,734

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	100	374	$18,255
2016	133	591	$27,580
2017	216	577	$28,544
2018	231	706	$14,745
2019	192	621	$26,903
2020	293	770	$49,418
2021	278	830	$61,533
2022	305	914	$71,703
2023	245	769	$44,483
2024	289	806	$51,411

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	532	1,188	$75
80061	Blood test, lipids (cholesterol and triglycerides)	490	719	$13
80053	Blood test, comprehensive group of blood chemicals	522	986	$10
36415	Insertion of needle into vein for collection of blood sample	540	1,214	$9
85025	Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count	470	788	$8

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Ozempic	Semaglutide	243	8,726	$258,726
Eliquis	Apixaban	218	10,792	$206,945
Jardiance	Empagliflozin	201	8,473	$162,315
Mounjaro	Tirzepatide	121	3,392	$120,156
Xarelto	Rivaroxaban	95	6,014	$111,110

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4239	Supply allowance for non-adjunctive, non-implanted continuous glucose monitor (cgm), includes all supplies and accessories, 1 month supply = 1 unit of service	N	11	48	$18,726
A7030	Full face mask used with positive airway pressure device, each	N	21	53	$5,177
A7031	Face mask interface, replacement for full face mask, each	N	20	47	$4,957
A7032	Cushion for use on nasal mask interface, replacement only, each	N	15	36	$3,703
E1390	Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate	Y	N/R	40	$3,478

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	152	$2,630	Astellas Pharma US Inc
Research Payments	Reported research-related payment or transfer-of-value amount.	17	$738,741	ModernaTX, Inc.
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Charles Harry Kemp, M.D.?

Tedicare shows public-source Medicare data for Charles Harry Kemp, M.D. (NPI 1093035784), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Charles Harry Kemp, M.D. have ACO affiliation data?

Charles Harry Kemp, M.D. is shown with ACO affiliation data for Privia Quality Network of Georgia (MSSP, ACO ID A3236) and Caravan Health ACO 50 LLC (MSSP, ACO ID A5160).

What billing organization is linked to Charles Harry Kemp, M.D.?

Charles Harry Kemp, M.D. is linked to PRIVIA MEDICAL GROUP OF GEORGIA LLC (billing NPI 1013313857) in the available physician profile data.

Does Charles Harry Kemp, M.D. have Open Payments data?

Charles Harry Kemp, M.D. has 169 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.